Our Recent Posts

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Nice shout-out from JobsOH for Cleveland HeartLab!

Please see the “Opportunities and Innovations in Ohio’s BioHealth Industry” video below. Companies like these are why we’ve been investing in the Midwest and specifically in Ohio for 15 years.

https://www.youtube.com/watch?v=lTsapNALw-A

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

Nice shout-out from JobsOH for Cleveland HeartLab!

©2024 by Mutual Capital Partners